John Talley Turns His Attention to Cancer Therapy

John Talley Turns His Attention to Cancer Therapy

For Euclises, it’s simple. Without the work of John Talley, Ph.D., the world would not have Celebrex®, the blockbuster arthritis treatment that has generated in excess of $3.5 billion in sales for Pfizer. Or Dynastat®, an injectable COX-2 inhibitor that’s sold in... Read more
Indalo Targets Idiopathic Pulmonary Fibrosis

Indalo Targets Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis is a highly progressive and life threatening disease affects approximately 130,000 people in the United States.  It’s worse than many cancers.  According to the National Institute of Health, physicians are unsure of the cause, but the... Read more